NCT00000674View on ClinicalTrials.gov

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 1992

Conditions
Toxoplasmosis, CerebralHIV Infections
Interventions
DRUG

Pyrimethamine

DRUG

Leucovorin calcium

DRUG

Clindamycin

Trial Locations (13)

10016

NY Univ. HIV/AIDS CRS, New York

10021

Cornell University A2201, New York

Memorial Sloan-Kettering Cancer Ctr., New York

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

15213

Pitt CRS, Pittsburgh

21287

Johns Hopkins Adult AIDS CRS, Baltimore

27599

Unc Aids Crs, Chapel Hill

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

33136

Univ. of Miami AIDS CRS, Miami

90033

USC CRS, Los Angeles

92103

Ucsd, Avrc Crs, San Diego

94304

Stanford CRS, Palo Alto

Unknown

Washington U CRS, St Louis

Sponsors

Collaborators (2)

Upjohn
Glaxo Wellcome
All Listed Sponsors
collaborator

Upjohn

INDUSTRY

collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000674 - A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS | Biotech Hunter | Biotech Hunter